These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 17201665
1. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes. Shi L, Liu S, Fan GX, Sheng L, Ren HX, Yuan YK. Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665 [Abstract] [Full Text] [Related]
3. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins. Satoi J, Murata K, Lechmann M, Manickan E, Zhang Z, Wedemeyer H, Rehermann B, Liang TJ. J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603 [Abstract] [Full Text] [Related]
4. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination. Vidalin O, Tanaka E, Spengler U, Trépo C, Inchauspé G. DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057 [Abstract] [Full Text] [Related]
6. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization. Hu GJ, Wang RY, Han DS, Alter HJ, Shih JW. Vaccine; 1999 Aug 06; 17(23-24):3160-70. PubMed ID: 10462252 [Abstract] [Full Text] [Related]
9. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus. Hiranuma K, Tamaki S, Nishimura Y, Kusuki S, Isogawa M, Kim G, Kaito M, Kuribayashi K, Adachi Y, Yasutomi Y. J Gen Virol; 1999 Jan 06; 80 ( Pt 1)():187-193. PubMed ID: 9934701 [Abstract] [Full Text] [Related]
10. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M, Holst PJ, Bukh J, Thomsen AR, Christensen JP. J Immunol; 2011 Feb 15; 186(4):2355-64. PubMed ID: 21257961 [Abstract] [Full Text] [Related]
12. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. Shirai M, Chen M, Arichi T, Masaki T, Nishioka M, Newman M, Nakazawa T, Feinstone SM, Berzofsky JA. J Infect Dis; 1996 Jan 15; 173(1):24-31. PubMed ID: 8537666 [Abstract] [Full Text] [Related]
16. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus. Kuprianov VV, Nikolaeva LI, Zykova AA, Dedova AV, Grishechkin AE, Kapustin IV, Kotlyarov RY, Ravin NV. Virus Res; 2020 Jul 15; 284():197984. PubMed ID: 32325116 [Abstract] [Full Text] [Related]
17. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen. Wei SH, Yin W, An QX, Lei YF, Hu XB, Yang J, Lu X, Zhang H, Xu ZK. Arch Virol; 2008 Jul 15; 153(6):1021-9. PubMed ID: 18421415 [Abstract] [Full Text] [Related]